合成生物学在多糖结合疫苗研发中的应用

叶精勤, 黄文华, 潘超, 朱力, 王恒樑 - 合成生物学, 2024 - synbioj.cip.com.cn
… , diphtheria toxoid, recombinant Pseudomonas aeruginosa … A systems approach to
designing next generation vaccines: … Producing a glycosylating Escherichia coli cell factory: the …

微藻叶绿体细胞器工厂研究进展

朱振, 田晶, 江静, 王旺银, 曹旭鹏 - 合成生物学, 2022 - synbioj.cip.com.cn
perspectives were also discussed. In the global effort for carbon neutralization, the microalgae
chloroplast organelle factories will … Engineering Cyanobacteria as cell factories for direct …

中华蜜蜂Apidaecin 的重组表达及其抗菌活性

陈文凤, 王红芳, 刘振国, 张卫星, 郗学鹏, 胥保华 - 中国农业科学, 2019 - chinaagrisci.com
… [Objective]In order to study the recombinant expression of antimicrobial peptide Apidaecin
… Bacillus subtilis, as cell factory for pharmaceutical proteins: a biotechnological approach to …

[HTML][HTML] 基于蛋白质跨外膜自转运系统的细菌细胞表面蛋白展示技术研究进展

蔡锟, 储引娣, 黄丕英, 韦良婉, 范恩国 - 微生物学报, 2022 - actamicro.ijournals.cn
recombinant proteins on bacterial cell surface. In this review, we first summarized the
subtypes, structural domains, and possible secretion mechanisms of autotransporters to enhance …

新型基因编辑技术加速盐藻表达系统的成熟和应用*

黄晓雯, 皇甫雨静, 姬聪浩, 代月优… - 中国生物工程 …, 2024 - manu60.magtech.com.cn
… of high value-added products such as recombinant proteins, lipid accumulation and carotene.
Due to the dual characteristics of prokaryotic and eukaryotic cells, salt algae have greater …

从CO2 到有机物——碳中和的微藻绿色生物制造

孙中亮, 陈辉, 王强 - 合成生物学, 2022 - synbioj.cip.com.cn
… recent years as “green cell factories”. From the perspective of light-driven autotrophy, we
summarize the latest progress of microalgae as a cell factory, introduce chassis transformation …

可基因编码点击化学在材料合成生物学中的应用

易琪昆, 孙晨博, 杨中光, 王日, 寇松姿, 李朝霞… - 合成生物学, 2022 - synbioj.cip.com.cn
… via GECCs, glimpse into the design of subunit vaccines, especially those against COVID-19, …
6 Application of GECC in recombinant protein vaccines Adapted from Ref. 91, 92 and 98 …

[PDF][PDF] 利用大肠埃希菌生产N-糖基化重组蛋白研究进展

胡学军, 李威, 吴琼, 丁宁 - 2023 - wswx.cnjournals.com
… N-glycosylated recombinant proteins with Escherichia coli,and reviewed the research
progress of N-glycosylated recombinant proteins and glycoconjugate vaccine via Escherichia coli,…

[PDF][PDF] 人胚胎来源细胞在生物医药领域的应用历史及研究和监管进展

高建超, 彭耀进, 韦薇, 鲁爽, 高晨燕 - 中国科学院院刊, 2024 - old2022.bulletin.cas.cn
… Observation on safety and immunogenicity of live polio vaccine type I of human diploid cell
strain … stem cell research policy: Comparative international perspectives and embryonic stem …

[HTML][HTML] 不同表达系统的治疗性纳米抗体研究进展

孙白荷, 吴悦, 赵芮, 楼雨馨, 李婉婷… - 中国生物工程 …, 2023 - manu60.magtech.com.cn
… Lactococcus lactis, an efficient cell factory for recombinant protein production and
secretion. Journal of Molecular Microbiology and Biotechnology, 2008, 14(1-3): 48-58. …